Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank13
3Y CAGR-18.8%
5Y CAGR-7.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-18.8%/yr
vs +13.6%/yr prior
5Y CAGR
-7.0%/yr
Recent deceleration
Acceleration
-32.4pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $172.00M | -37.0% |
| 2024 | $273.22M | -16.7% |
| 2023 | $327.83M | +2.0% |
| 2022 | $321.40M | +9.2% |
| 2021 | $294.28M | +19.3% |
| 2020 | $246.70M | +22.1% |
| 2019 | $202.01M | +4.8% |
| 2018 | $192.84M | +9642000.0% |
| 2017 | $2000.00 | - |